TXNIP and metabolic dysfunction-associated steatotic liver disease: Our research elucidates the critical role of the circSOD2/miR-532-3p/TXNIP/NLRP3 pathway in NAFLD, establishing a new molecular mechanism for the development and progression of NAFLD and offering alternative therapeutic avenues.